DermaSensor Private
DermaSensor offers a non-invasive, AI-powered skin cancer and melanoma detection device. Discover our early detection technology that revolutionizes skin cancer diagnostics and screening, improving patient outcomes.
Industry:
PharmTech
Headquarters:
Miami, Florida, United States
Estimated Revenue:
$132,743.5 million
Employee Number:
11-50